Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12613000495729Phase 3Recruiting
Phase 3, randomised, double-blind trial in mitral stenosis (MS) comparing Dexmedetomidine with Placebo saline (2 arms). Primary endpoint: Heart rate changes. Started Nov 2011; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12613000495729.